Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis.
Sign Up to like & getrecommendations! Published in 2017 at "Blood advances"
DOI: 10.1182/bloodadvances.2017007526
Abstract: Optimal salvage therapy for refractory HLH is unknown.In our patient, ruxolitinib treatment led to clinical remission of refractory HLH. read more here.
Keywords: refractory hemophagocytic; ruxolitinib treatment; treatment refractory; hemophagocytic lymphohistiocytosis ... See more keywords